Two-Minute Drill: JAZZ, BIIB & BABA
Jessica Inskip, OptionsPlay director, joins ‘Closing Bell: Overtime’ to give her favorite stock picks in this market, including Jazz Pharma, Biogen and Alibaba.
UP NEXT
NOW PLAYING: Money
Two-Minute Drill: JAZZ, BIIB & BABA
CNBC
UP NEXT
-
ECB will not be able to hike much after September, Fidelity's Salman Ahmed says
CNBC
-
Big Ten media deal a 'game changer' for the conference, member schools, says Bruin Capital CEO
-
Should regulators probe Ryan Cohen's Bed Bath & Beyond stake? Former SEC Chair weighs in
-
The Pre Market Rundown 2: Aug. 19, 2022
-
Cannabis stocks rally as U.S. lawmakers mull federal legislation
-
Forgiving student loan debt across the board is 'outrageous,' says former U.S. Sen. Judd Gregg
-
Buy high-quality names amid a potential bout of market weakness, says NewEdge Wealth CIO
-
This will be a 'really tough' winter for energy prices, says Energy Intelligence's Amena Bakr
-
Now is a 'particularly stupid' time to enact new corporate taxes, says Grover Norquist
-
Big Ten strikes media deal reportedly worth $7.5 billion
-
Now is not the time to go bargain hunting for Meta stock, says Independent Solutions' Paul Meeks
-
Just Eat Takeaway soars on Brazil unit sale
Reuters
-
Wood Mackenzie: The supply situation we're in right now for gasoline is much better than back in June
-
Navitas CEO: We need to reduce our reliance on legacy semiconductor chips
-
Wright: Investors should focus on time in the market, rather than timing the market
-
There needs to be a deep recession for enough demand destruction to bring down energy prices: SocGen
-
Fernandez: We're in a stock picker's market right now
-
The Pre-Markets Rundown: Aug. 19, 2022
-
Schroders: UK retail figures 'very strong' despite double-digit inflation
-
Expect ECB to raise interest rates by no more than 50 basis points in September: Economist
-
After Starbucks exit, 'Stars Coffee' debuts in Russia
-
Wealth management firm names areas of opportunity in India's stock market
